Brii Biosciences Limited
BRIBF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,508 | $1,003 | $656 | $490 |
| Short-Term Investments | $567 | $1,317 | $1,731 | $2,171 |
| Receivables | $0 | $0 | $0 | $17 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $14 | $94 | $173 | $105 |
| Total Curr. Assets | $2,089 | $2,414 | $2,559 | $2,783 |
| Property Plant & Equip (Net) | $11 | $14 | $2 | $6 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $304 | $180 | $269 | $267 |
| Long-Term Investments | $7 | -$1,308 | $23 | -$2,029 |
| Tax Assets | $0 | $0 | $0 | -$142 |
| Other NC Assets | $74 | $1,406 | $43 | $2,313 |
| Total NC Assets | $396 | $293 | $337 | $415 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,485 | $2,707 | $2,897 | $3,198 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $5 | $5 | $1 | $3 |
| Tax Payable | $0 | $1 | $2 | $2 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $44 | $71 | $65 | $121 |
| Total Curr. Liab. | $49 | $77 | $68 | $126 |
| LT Debt | $3 | $23 | $19 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $3 | $23 | $19 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $10 | $2 | $3 |
| Total Liabilities | $51 | $101 | $86 | $126 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $0 | -$7,205 | -$6,978 | -$6,697 |
| AOCI | $2,485 | $0 | $456 | $439 |
| Other Equity | $0 | $9,862 | $9,381 | $9,377 |
| Total Equity | $2,485 | $2,657 | $2,860 | $3,119 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$52 | -$51 | -$49 | -$47 |
| Total Liab. & Tot. Equity | $2,485 | $2,707 | $2,897 | $3,198 |
| Net Debt | -$1,500 | -$975 | -$637 | -$486 |